Journal
JOURNAL OF CONTROLLED RELEASE
Volume 162, Issue 1, Pages 194-200Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2012.06.014
Keywords
Solutol (R) HS15; Nasal delivery; hGH; Absorption enhancer; Bioadhesive formulations
Ask authors/readers for more resources
The absorption enhancing efficiency of CriticalSorb (TM) for human growth hormone ( MW 22 kDa) was investigated in the conscious rat model. The principle absorption enhancing component of CriticalSorb (TM), Solutol (R) HS15, comprises polyglycol mono- and di-esters of 12-hydroxystearic acid combined with free polyethylene glycol. When administering hGH nasally in rats with increasing concentrations of Solutol (R) HS15, it was found that for a 10% w/v solution formulation a bioavailability of 49% was obtained in the first 2 h after administration. Furthermore it was shown that the most effective ratio of Solutol (R) HS15 to hGH was 4: 1 on a mg to mg basis. Histopathology studies in rats after 5 days repeated nasal administration showed that Solutol (R) HS15 had no toxic effect on the nasal mucosa. These results have been confirmed in a 6 month repeat nasal toxicity study in rats. It can be concluded that the principle absorption enhancing component of CriticalSorb (TM) Solutol (R) HS15 - is a potent and non- toxic nasal absorption enhancer that warrants further development. (C) 2012 Elsevier B. V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available